| Issue Date | Title | Author(s) |
| 2022-01-01 | Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure: A Post Hoc Analysis of Data From the GALACTIC-HF Randomized Clinical Trial. | Felker, GM; Solomon, SD; Claggett, B; Diaz, R; McMurray, JJV; Metra, M; Anand, I; Crespo-Leiro, MG; Dahlström, U; Goncalvesova, E; Howlett, JG; MacDonald, P; Parkhomenko, A; Tomcsányi, J; Abbasi, SA; Heitner, SB; Hucko, T; Kupfer, S; Malik, FI; Teerlink, JR |
| 2018-10-18 | Exploring the cardiac response to injury in heart transplant biopsies | Halloran, PF; Reeve, J; Aliabadi, AZ; Cadeiras, M; Crespo-Leiro, MG; Deng, M; Depasquale, EC; Goekler, J; Jouven, X; Kim, DH; Kobashigawa, J; Loupy, A; Macdonald, P; Potena, L; Zuckermann, A; Parkes, MD |
| 2019-06-01 | An integrated molecular diagnostic report for heart transplant biopsies using an ensemble of diagnostic algorithms | Parkes, MD; Aliabadi, AZ; Cadeiras, M; Crespo-Leiro, MG; Deng, M; Depasquale, EC; Goekler, J; Kim, DH; Kobashigawa, J; Loupy, A; Macdonald, P; Potena, L; Zuckermann, A; Halloran, PF |
| 2022-01-01 | Many heart transplant biopsies currently diagnosed as no rejection have mild molecular antibody-mediated rejection-related changes. | Halloran, PF; Madill-Thomsen, K; Aliabadi-Zuckermann, AZ; Cadeiras, M; Crespo-Leiro, MG; Depasquale, EC; Deng, M; Gökler, J; Kim, DH; Kobashigawa, J; Macdonald, P; Potena, L; Shah, K; Stehlik, J; Zuckermann, A |
| 2023-11-30 | Molecular states associated with dysfunction and graft loss in heart transplants. | Halloran, PF; Madill-Thomsen, K; Mackova, M; Aliabadi-Zuckermann, AZ; Cadeiras, M; Crespo-Leiro, MG; Depasquale, EC; Deng, M; Gökler, J; Hall, SA; Kim, DH; Kobashigawa, J; Macdonald, P; Potena, L; Shah, K; Stehlik, J; Zuckermann, A; Reeve, J |
